| 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus A Fanouriakis, M Kostopoulou, A Alunno, M Aringer, I Bajema, JN Boletis, ... Annals of the rheumatic diseases 78 (6), 736-745, 2019 | 1759 | 2019 |
| Pathologic classification of diabetic nephropathy TWC Tervaert, AL Mooyaart, K Amann, AH Cohen, HT Cook, ... Journal of the American Society of Nephrology 21 (4), 556-563, 2010 | 1731 | 2010 |
| EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis M Yates, RA Watts, IM Bajema, MC Cid, B Crestani, T Hauser, B Hellmich, ... Annals of the rheumatic diseases 75 (9), 1583-1594, 2016 | 1336 | 2016 |
| Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of … GK Bertsias, M Tektonidou, Z Amoura, M Aringer, I Bajema, JHM Berden, ... Annals of the rheumatic diseases 71 (11), 1771-1782, 2012 | 1228 | 2012 |
| Histopathologic classification of ANCA-associated glomerulonephritis AE Berden, F Ferrario, EC Hagen, DR Jayne, JC Jennette, K Joh, ... Journal of the American Society of Nephrology 21 (10), 1628-1636, 2010 | 927 | 2010 |
| Revision of the International Society of Nephrology/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes … IM Bajema, S Wilhelmus, CE Alpers, JA Bruijn, RB Colvin, HT Cook, ... Kidney international 93 (4), 789-796, 2018 | 716 | 2018 |
| C3 glomerulopathy: consensus report MC Pickering, VD D'agati, CM Nester, RJ Smith, M Haas, GB Appel, ... Kidney international 84 (6), 1079-1089, 2013 | 692 | 2013 |
| 2019 update of the joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA–EDTA) recommendations for the … A Fanouriakis, M Kostopoulou, K Cheema, HJ Anders, M Aringer, ... Annals of the rheumatic diseases 79 (6), 713-723, 2020 | 672 | 2020 |
| Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a “Kidney Disease: Improving Global Outcomes”(KDIGO) Controversies Conference THJ Goodship, HT Cook, F Fakhouri, FC Fervenza, V Frémeaux-Bacchi, ... Kidney international 91 (3), 539-551, 2017 | 649 | 2017 |
| Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease APJ De Vries, P Ruggenenti, XZ Ruan, M Praga, JM Cruzado, IM Bajema, ... The lancet Diabetes & endocrinology 2 (5), 417-426, 2014 | 429 | 2014 |
| Autologous bone marrow-derived mesenchymal stromal cells for the treatment of allograft rejection after renal transplantation: results of a phase I study MEJ Reinders, JW de Fijter, H Roelofs, IM Bajema, DK de Vries, ... Stem cells translational medicine 2 (2), 107-111, 2013 | 381 | 2013 |
| Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups HA Hauer, IM Bajema, HC Van Houwelingen, F Ferrario, LH Noël, ... Kidney international 61 (1), 80-89, 2002 | 381 | 2002 |
| Anti-C1q autoantibodies deposit in glomeruli but are only pathogenic in combination with glomerular C1q-containing immune complexes LA Trouw, TWL Groeneveld, MA Seelen, JMGJ Duijs, IM Bajema, FA Prins, ... The Journal of clinical investigation 114 (5), 679-688, 2004 | 320 | 2004 |
| Mayo clinic/renal pathology society consensus report on pathologic classification, diagnosis, and reporting of GN S Sethi, M Haas, GS Markowitz, VD D’Agati, HG Rennke, JC Jennette, ... Journal of the American Society of Nephrology 27 (5), 1278-1287, 2016 | 287 | 2016 |
| The MEST score provides earlier risk prediction in lgA nephropathy SJ Barbour, G Espino-Hernandez, HN Reich, R Coppo, ISD Roberts, ... Kidney international 89 (1), 167-175, 2016 | 265 | 2016 |
| Determinants of outcome in ANCA-associated glomerulonephritis: a prospective clinico-histopathological analysis of 96 patients HA Hauer, IM Bajema, HC Van Houwelingen, F Ferrario, LH Noël, ... Kidney international 62 (5), 1732-1742, 2002 | 262 | 2002 |
| EULAR points to consider in the development of classification and diagnostic criteria in systemic vasculitis N Basu, R Watts, I Bajema, B Baslund, T Bley, M Boers, P Brogan, ... Annals of the rheumatic diseases 69 (10), 1744-1750, 2010 | 244 | 2010 |
| Pros and cons for C4d as a biomarker D Cohen, RB Colvin, MR Daha, CB Drachenberg, M Haas, V Nickeleit, ... Kidney international 81 (7), 628-639, 2012 | 243 | 2012 |
| Kidney biopsy as a predictor for renal outcome in ANCA-associated necrotizing glomerulonephritis IM Bajema, EC Hagen, J Hermans, LH Noël, R Waldherr, F Ferrario, ... Kidney international 56 (5), 1751-1758, 1999 | 242 | 1999 |
| Differences in synovial tissue infiltrates between anti–cyclic citrullinated peptide–positive rheumatoid arthritis and anti–cyclic citrullinated peptide–negative rheumatoid … M Van Oosterhout, I Bajema, EWN Levarht, REM Toes, TWJ Huizinga, ... Arthritis & Rheumatism 58 (1), 53-60, 2008 | 226 | 2008 |
